Acute flaccid paralysis

1. Acute Flaccid Paralysis

Acute flaccid paralysis (AFP) is a clinical syndrome characterized by the sudden onset of weakness or paralysis in one or more limbs, without other obvious causes such as trauma. It is a critical condition that requires immediate medical attention to determine the underlying cause and initiate appropriate treatment.

Etiology

AFP can be caused by a variety of infectious and non-infectious agents. The most notable infectious cause is the poliovirus, which can lead to poliomyelitis. Other viral causes include enteroviruses, West Nile virus, and adenoviruses. Non-infectious causes can include Guillain-Barré syndrome, transverse myelitis, and spinal cord injury.

Clinical Presentation

Patients with AFP typically present with sudden onset of weakness in one or more limbs. The weakness is often asymmetric and can progress rapidly. In some cases, patients may also experience respiratory failure if the muscles involved in breathing are affected. Sensory loss is usually not a prominent feature, distinguishing it from other neurological conditions.

Diagnosis

The diagnosis of AFP involves a thorough clinical evaluation, including a detailed history and physical examination. Laboratory tests such as cerebrospinal fluid analysis, electromyography, and nerve conduction studies may be performed. Imaging studies like MRI of the spine can help identify structural causes of paralysis. Stool samples may be collected to test for poliovirus and other enteroviruses.

Management

Management of AFP depends on the underlying cause. In cases of poliovirus infection, supportive care and rehabilitation are essential. For Guillain-Barré syndrome, treatments such as plasmapheresis or intravenous immunoglobulin (IVIG) may be used. Early intervention and supportive care, including respiratory support if needed, are crucial to improve outcomes.

Prevention

Vaccination is the most effective way to prevent poliovirus-related AFP. The oral polio vaccine (OPV) and inactivated polio vaccine (IPV) are used worldwide to prevent poliomyelitis. Public health measures to control outbreaks of other viral infections can also help reduce the incidence of AFP.

Epidemiology

AFP is a rare condition, but it is a critical indicator for polio surveillance programs. The World Health Organization (WHO) recommends that all cases of AFP in children under 15 years of age be reported and investigated to rule out poliovirus infection.

Also see

• Poliomyelitis
• Guillain-Barré syndrome
• Transverse myelitis
• West Nile virus
• Nerve conduction study

edit 

WikiMD neurology

External links

• Comprehensive information from the National Institute of health.
  

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z